INFINITY PHARMACEUTICALS, INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Infinity Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q2 2023.
  • Infinity Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2023 was $164K, a 413% increase year-over-year.
  • Infinity Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was $1.1M.
  • Infinity Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $475K.
  • Infinity Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$179K, a 91% increase from 2020.
  • Infinity Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2020 was -$2M, a 37.9% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $1.1M $164K +$132K +413% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $966K $462K +$491K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $475K $308K +$459K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 $16K $164K +$127K +343% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$111K $32K +$50K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$161K -$29K +$18K +38.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$179K -$151K +$215K +58.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$394K $37K +$726K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.12M -$18K +$536K +96.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$1.66M -$47K +$339K +87.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$2M -$366K -$539K -312% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$1.46M -$689K +$147K +17.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$1.6M -$554K +$215K +28% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-27
Q1 2020 -$1.82M -$386K -$371K -2473% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$1.45M $173K -$63K -26.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$1.38M -$836K -$1.04M -514% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$346K -$769K -$941K -547% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $595K -$15K -$81K -123% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $676K $236K +$233K +7767% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 $443K $202K -$537K -72.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $980K $172K +$7.02M Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 -$6.04M $66K +$65K +6500% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$6.11M $3K -$300K -99% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-15
Q3 2017 -$5.81M $739K +$303K +69.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$6.11M -$6.85M -$6.8M -12821% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $687K $1K -$103K -99% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $790K $303K +$477K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 $313K $436K +$672K Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 -$359K -$53K -$217K -132% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$142K $104K +$791K Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
Q4 2015 -$933K -$174K +$878K +83.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$1.81M -$236K +$4.25M +94.7% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$6.06M $164K +$2.97M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 -$9.03M -$687K +$284K +29.2% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 -$9.31M -$1.05M -$1.21M -762% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-23
Q3 2014 -$8.1M -$4.49M -$4.72M -1984% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-23
Q2 2014 -$3.38M -$2.8M -$2.97M -1809% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-23
Q1 2014 -$410K -$971K -$1.31M -390% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-23
Q4 2013 $896K $159K +$17K +12% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-24
Q3 2013 $879K $238K +$601K Jul 1, 2013 Sep 30, 2013 10-K 2015-02-24
Q2 2013 $278K $164K +$538K Apr 1, 2013 Jun 30, 2013 10-K 2015-02-24
Q1 2013 -$260K $335K +$896K Jan 1, 2013 Mar 31, 2013 10-K 2015-02-24
Q4 2012 -$1.16M $142K +$591K Oct 1, 2012 Dec 31, 2012 10-K 2014-02-25
Q3 2012 -$1.75M -$363K -$1K -0.28% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-25
Q2 2012 -$1.75M -$374K -$10K -2.75% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-25
Q1 2012 -$1.74M -$561K -$222K -65.5% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-25
Q4 2011 -$1.51M -$449K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-05
Q3 2011 -$362K +$37.3K +9.33% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-05
Q2 2011 -$364K +$44.2K +10.8% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-05
Q1 2011 -$339K Jan 1, 2011 Mar 31, 2011 10-K 2013-03-05
Q3 2010 -$399K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$408K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.